Collaboration in Times of Crisis: A Study on COVID-19 Vaccine R&D Partnerships
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 282 KB, PDF document
This paper provides an empirical investigation into the types of partnerships that have emerged during the pandemic to develop COVID-19 vaccines and to identify relevant factors that characterize these partnerships. We provide legal and policy considerations to our results that suggest an opportunity for policymakers to help shift the collaborative landscape to increase the potential for knowledge-sharing, the development of fundamental insight, and the adequate production of resulting technological goods, both in this pandemic and the next.
Volume 39, Issue 42, 8 October 2021, Pages 6291-6295
Volume 39, Issue 42, 8 October 2021, Pages 6291-6295
Original language | English |
---|---|
Journal | Vaccine |
Volume | 39 |
Issue number | 42 |
Pages (from-to) | 6291 - 6295 |
ISSN | 0264-410X |
DOIs | |
Publication status | Published - 8 Oct 2021 |
- Faculty of Law - Legal considerations, Pharmaceutical policy, COVID-19, Vaccine, knowledge sharing, empirical legal studies, empirical research
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 276122727